Go Pro
→ Your book attached (From Profits Run) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
$0.03
$0.65
$0.03
▼
$0.59
$857K0.226.48 million shsN/A
HTGMQ
HTG Molecular Diagnostics
$0.00
$0.00
▼
$0.00
N/A31,989 shsN/A
60 Degrees Pharmaceuticals Inc. stock logo
SXTP
60 Degrees Pharmaceuticals
$0.90
-0.2%		$1.23
$0.88
▼
$8.62
$3.17M2.5453,313 shs109,262 shs
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
$0.00
$0.00
▼
$0.00
$1K1.09991 shsN/A
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
0.00%0.00%0.00%0.00%-16.05%
HTGMQ
HTG Molecular Diagnostics
0.00%0.00%0.00%0.00%0.00%
60 Degrees Pharmaceuticals Inc. stock logo
SXTP
60 Degrees Pharmaceuticals
-0.17%-2.26%-24.81%-38.46%-83.96%
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
$0.03
$0.65
$0.03
▼
$0.59
$857K0.226.48 million shsN/A
HTGMQ
HTG Molecular Diagnostics
$0.00
$0.00
▼
$0.00
N/A31,989 shsN/A
60 Degrees Pharmaceuticals Inc. stock logo
SXTP
60 Degrees Pharmaceuticals
$0.90
-0.2%		$1.23
$0.88
▼
$8.62
$3.17M2.5453,313 shs109,262 shs
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
$0.00
$0.00
▼
$0.00
$1K1.09991 shsN/A
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
0.00%0.00%0.00%0.00%-16.05%
HTGMQ
HTG Molecular Diagnostics
0.00%0.00%0.00%0.00%0.00%
60 Degrees Pharmaceuticals Inc. stock logo
SXTP
60 Degrees Pharmaceuticals
-0.17%-2.26%-24.81%-38.46%-83.96%
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
0.00
N/AN/AN/A
HTGMQ
HTG Molecular Diagnostics
0.00
N/AN/AN/A
60 Degrees Pharmaceuticals Inc. stock logo
SXTP
60 Degrees Pharmaceuticals
2.00
Hold$13.851,441.46% Upside
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest AXDX, THMO, HTGMQ, and SXTP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/24/2026
60 Degrees Pharmaceuticals Inc. stock logo
SXTP
60 Degrees Pharmaceuticals
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
(Data available from 9/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
$11.70M0.07N/AN/A($1.37) per share-0.02
HTGMQ
HTG Molecular Diagnostics
$6.37M0.00N/AN/AN/ANaN
60 Degrees Pharmaceuticals Inc. stock logo
SXTP
60 Degrees Pharmaceuticals
$1.41M2.24N/AN/A($5.85) per share-0.15
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
$9.61M0.00N/AN/A($0.99) per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
-$61.62M-$2.34N/AN/AN/A-471.83%N/A-191.66%N/A
HTGMQ
HTG Molecular Diagnostics
-$21.59MN/AN/AN/AN/AN/AN/AN/AN/A
60 Degrees Pharmaceuticals Inc. stock logo
SXTP
60 Degrees Pharmaceuticals
-$7.36M-$4.82N/AN/AN/A-650.21%N/A-136.81%11/12/2026 (Estimated)
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
-$17.98M-$5.14N/AN/AN/AN/AN/AN/AN/A

Latest AXDX, THMO, HTGMQ, and SXTP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
60 Degrees Pharmaceuticals Inc. stock logo
SXTP
60 Degrees Pharmaceuticals
-$0.74-$0.90-$0.16-$0.90$0.21 million$0.21 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
N/AN/AN/AN/AN/A
HTGMQ
HTG Molecular Diagnostics
N/AN/AN/AN/AN/A
60 Degrees Pharmaceuticals Inc. stock logo
SXTP
60 Degrees Pharmaceuticals
N/AN/AN/AN/AN/A
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
N/A
1.50
1.34
HTGMQ
HTG Molecular Diagnostics
N/AN/AN/A
60 Degrees Pharmaceuticals Inc. stock logo
SXTP
60 Degrees Pharmaceuticals
N/A
2.32
1.78
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
17.14%
HTGMQ
HTG Molecular Diagnostics
N/A
60 Degrees Pharmaceuticals Inc. stock logo
SXTP
60 Degrees Pharmaceuticals
7.96%
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
5.78%

Insider Ownership

CompanyInsider Ownership
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
43.60%
HTGMQ
HTG Molecular Diagnostics
2.60%
60 Degrees Pharmaceuticals Inc. stock logo
SXTP
60 Degrees Pharmaceuticals
1.68%
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
78.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Accelerate Diagnostics, Inc. stock logo
AXDX
Accelerate Diagnostics
22025.21 million14.13 millionNo Data
HTGMQ
HTG Molecular Diagnostics
90630,0002.16 millionNot Optionable
60 Degrees Pharmaceuticals Inc. stock logo
SXTP
60 Degrees Pharmaceuticals
33.52 million3.46 millionNot Optionable
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
407.95 million1.75 millionNot Optionable

Recent News About These Companies

ThermoGenesis Holdings Inc.
July 27, 2026  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/thmo/financials
CitrusBurn Analyzed (INSIDER REPORT) Does Citrus Burn Natural Weight Loss Supplement Really Work? Achieves 74% Thermogenesis Increase in Clinical Studies
February 19, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/02/19/3241422/0/en/citrusburn-analyzed-insider-report-does-citrus-burn-natural-weight-loss-supplement-really-work-achieves-74-thermogenesis-increase-in-clinical-studies.html
THMO | ThermoGenesis Holdings Inc. Annual Cash Flow Statement | MarketWatch
July 29, 2025  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/thmo/financials/cash-flow
The Ice Water Hack: How Aqua Sculpt Boosts Thermogenesis for Fat Loss
March 10, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/03/10/3039487/0/en/the-ice-water-hack-how-aqua-sculpt-boosts-thermogenesis-for-fat-loss.html
Ice Water Hack: How Aqua Sculpt Improves Thermogenesis for Weight Loss
February 20, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/02/20/3029625/0/en/ice-water-hack-how-aqua-sculpt-improves-thermogenesis-for-weight-loss.html
North American Morning Briefing: Stock Futures, -2-
September 19, 2024  |  morningstar.comM
Is Thermogenesis Holdings Inc Stock (THMO) a Good Investment?
August 8, 2024  |  aaii.comA
ThermoGenesis Holdings (OTC:THMO) Stock Quotes, Forecast and News Summary
July 28, 2024  |  benzinga.comhttps://www.benzinga.com/quote/THMO
ThermoGenesis Holdings (OTC:THMO) Stock, Short Interest Report
July 28, 2024  |  benzinga.comhttps://www.benzinga.com/quote/THMO/short-interest
Why Is ThermoGenesis (THMO) Stock Down 37% Today?
June 12, 2024  |  investorplace.comhttps://investorplace.com/2024/06/why-is-thermogenesis-thmo-stock-down-37-today/
THMO Stock Earnings: ThermoGenesis Holdings Misses EPS, Misses Revenue for Q1 2024
May 17, 2024  |  investorplace.comhttps://investorplace.com/earning-results/2024/05/thmo-stock-earnings-thermogenesis-holdings-for-q1-of-2024/?cc=marketbeat&cp=pdtk
ThermoGenesis Holdings, Inc.
January 9, 2024  |  thestreet.comhttps://www.thestreet.com/quote/THMO
ThermoGenesis Holdings Stock (NASDAQ:THMO) Dividends: History, Yield and Dates
December 16, 2023  |  benzinga.comhttps://www.benzinga.com/quote/THMO/dividend
Shareholders Will Probably Hold Off On Increasing ThermoGenesis Holdings, Inc.'s (NASDAQ:THMO) CEO Compensation For The Time Being
December 8, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/shareholders-probably-hold-off-increasing-100950163.html?.tsrc=rss
ThermoGenesis Holdings Recent Insider Activity
November 21, 2023  |  benzinga.comhttps://www.benzinga.com/news/23/11/35896638/thermogenesis-holdings-recent-insider-activity
ThermoGenesis Holdings, Inc.: ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update
November 15, 2023  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2023-11/60655064-thermogenesis-holdings-inc-thermogenesis-holdings-announces-third-quarter-2023-financial-results-and-provides-corporate-update-008.htm
ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q3 2023 Earnings Call Transcript
November 14, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/thermogenesis-holdings-inc-nasdaq-thmo-152609944.html?.tsrc=rss
ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update
November 13, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/thermogenesis-holdings-announces-third-quarter-210500777.html?.tsrc=rss
ThermoGenesis Q3 Earnings Preview
November 12, 2023  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/thermogenesis-q3-earnings-preview/ar-AA1jOtWr
Here's what Wall Street expects from ThermoGenesis's earnings report
November 12, 2023  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/thermogenesis_2-stock-price-quarter-earnings-preview-q3-1032809562

New MarketBeat Followers Over Time

Media Sentiment Over Time

Accelerate Diagnostics stock logo

Accelerate Diagnostics NASDAQ:AXDX

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.

HTG Molecular Diagnostics NASDAQ:HTGMQ

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq Oncology Biomarker Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona. On June 5, 2023, HTG Molecular Diagnostics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

60 Degrees Pharmaceuticals stock logo

60 Degrees Pharmaceuticals NASDAQ:SXTP

$0.90 0.00 (-0.17%)
Closing price 09/14/2026 04:00 PM Eastern
Extended Trading
$0.90 +0.00 (+0.17%)
As of 09/14/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is headquartered in Washington, the District of Columbia.

ThermoGenesis stock logo

ThermoGenesis NASDAQ:THMO

ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics in the United States, China, the United Arab Emirates, Vietnam, and internationally. The company provides medical device products for automated cell processing. Its clinical bio-banking applications include AXP II Automated Cell Separation System, an automated fully closed cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. The company's point-of-care applications include XP Point-of-Care System, an automated, fully closed, sterile system that allows for the rapid and automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; and PXP-1000 System, an automated, fully closed system that provides fast, reproducible separation of multiple cellular components from blood with minimal red blood cell contamination. Its cell processing products comprise X-Series products for general laboratory use, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The company also provides contract development and manufacturing services for cell and cell-based gene therapies. It markets and sells its medical device products through independent distributors, as well as direct to end-user customers. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas